These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29948641)

  • 21. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
    Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
    Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative.
    Chakraborty S; Chakravarty R; Vatsa R; Bhusari P; Sarma HD; Shukla J; Mittal BR; Dash A
    Nucl Med Biol; 2016 Jan; 43(1):116-123. PubMed ID: 26527030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [
    Lang CI; Döring P; Gäbel R; Vasudevan P; Lemcke H; Müller P; Stenzel J; Lindner T; Joksch M; Kurth J; Bergner C; Wester HJ; Ince H; Steinhoff G; Vollmar B; David R; Krause BJ
    Cells; 2020 May; 9(6):. PubMed ID: 32486211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Szabo JP; Denes N; Arato V; Racz S; Kis A; Opposits G; Kepes Z; Hajdu I; Joszai I; Emri M; Kertesz I; Mezo G; Trencsenyi G
    In Vivo; 2022; 36(4):1667-1675. PubMed ID: 35738627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.
    Corroyer-Dulmont A; Pérès EA; Gérault AN; Savina A; Bouquet F; Divoux D; Toutain J; Ibazizène M; MacKenzie ET; Barré L; Bernaudin M; Petit E; Valable S
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):682-94. PubMed ID: 26537287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of a dual-receptor targeted tracer [
    Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
    Beinat C; Patel CB; Xie Y; Gambhir SS
    Mol Imaging Biol; 2020 Feb; 22(1):124-133. PubMed ID: 30989436
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Zhao ZQ; Ji S; Li XY; Fang W; Liu S
    Appl Radiat Isot; 2019 Jun; 148():168-177. PubMed ID: 30959354
    [No Abstract]   [Full Text] [Related]  

  • 32. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.
    Warnock G; Turtoi A; Blomme A; Bretin F; Bahri MA; Lemaire C; Libert LC; Seret AE; Luxen A; Castronovo V; Plenevaux AR
    J Nucl Med; 2013 Oct; 54(10):1782-8. PubMed ID: 23970367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.
    Prignon A; Nataf V; Provost C; Cagnolini A; Montravers F; Gruaz-Guyon A; Lantry LE; Talbot JN; Nunn AD
    Nucl Med Biol; 2015 Feb; 42(2):92-8. PubMed ID: 25459112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapy.
    Shi J; Jin Z; Liu X; Fan D; Sun Y; Zhao H; Zhu Z; Liu Z; Jia B; Wang F
    Mol Pharm; 2014 Nov; 11(11):3915-22. PubMed ID: 25158145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
    Kazmierczak PM; Todica A; Gildehaus FJ; Hirner-Eppeneder H; Brendel M; Eschbach RS; Hellmann M; Nikolaou K; Reiser MF; Wester HJ; Kropf S; Rominger A; Cyran CC
    PLoS One; 2016; 11(12):e0168248. PubMed ID: 27992512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment.
    Xue W; Du X; Wu H; Liu H; Xie T; Tong H; Chen X; Guo Y; Zhang W
    Sci Rep; 2017 Oct; 7(1):13894. PubMed ID: 29066764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [
    Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
    Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.